Not baffling, Orthocell is a company with big dreams and our share price gets treated like any other small cap, when theres no competition in buying why would you increase your price for shares, history has proven its only a matter of time before the seller start selling down to the market.
First time for everything, I sold 100 thousand the other day, dont stress Ive still got over 1 million under the pillow, personally Im going to need too see some big changes for the new year, 2022.
1. Striate+ partnered up in the USA
2. Ortho-ATI partnered up for phase three trials in the USA
3. Ortho-ATI, FDA approvals
4. Celgro - Nerve ( anything really )
5. Ortho - ACL ( rope ) animal studies completed ready for human trials
J&J Partnership, page-365
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
61.0¢ |
Change
-0.010(1.61%) |
Mkt cap ! $145.8M | |||
| Open | High | Low | Value | Volume |
| 62.5¢ | 63.0¢ | 61.0¢ | $1.181M | 1.913M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5445 | 61.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 62.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| OCC (ASX) Chart |